Bolt - BOLT

Option chain shows key data for Bolt Biotherapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Bolt Biotherapeutics.

Bolt Biotherapeutics (NASDAQ:BOLT) Stock, Option Chain

Bolt Biotherapeutics

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

Screenshot 2024-12-06 at 6.41.42 PM

Emerging Markets

Commodities

Movers & Shakers

Markets

BOLT

PACIFIC RIM COBALT CORP by Pacific Rim Cobalt Corp.

PCRCF

Bolt Metals Corp. (CSE: BOLT) Makes A Power Move: Strategic Acquisition Of Copper-Silver Assets Signals Expansion

movers

News

Intraday Update

Movers

AEMD

ARQT

AWIN

BCRX

BSFC

CABA

CDRO

CRKN

CSLR

CTNT

DELL

DLPN

EDBL

FFIE

GWAV

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

INTZ

IRBT

JFBR

KOSS

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

MNDY

NOVA

NSYS

NTRB

NVAX

OPRX

PEGY

PLSE

PXLW

RIVN

RSKD

SINT

SLNA

SPCE

SPWR

VRPX

VTSI

YTEN

Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

Prague,cz,-27,April,2023:,Logo,On,Accenture,Headquarters,In,Prague.

Downgrades

Analyst Ratings

Trading Ideas

AMRK

This Accenture Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Today

Bolt Biotherapeutics, Inc. - Common Stock

Bolt Biotherapeutics Inc

Bolt Metals Corp

Bolt Projects Holdings, Inc. - Common Stock

Bolt Projects Holdings Inc

Legal

Press Releases

BOLT Investors Have the Opportunity to Lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

BOLT Deadline: Rosen Law Firm Urges Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Penny Stocks

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Bolt Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - BOLT

Management

Bolt Biotherapeutics Announces Changes to its Board of Directors

Health Care

Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting

Earnings

Bolt Biotherapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.

Bolt Biotherapeutics to Participate in Upcoming March Conferences

ABVC BioPharma

BioAtla

Carisma Therapeutics, Inc. - Common Stock

CARISMA Therapeutics

Calidi Biotherapeutics, Inc. Common Stock

Calidi Biotherapeutics

CervoMed

Eterna Therapeutics

GlycoMimetics

HCW Biologics

HOOKIPA Pharma

IN8bio

Kairos Pharma

Longeveron

Leap Therapeutics

Lisata Therapeutics

MEI Pharma

Marker Therapeutics

NKGen Biotech

Nanoviricides

NextCure

SAB Biotherapeutics

Senti Biosciences

Spruce Biosciences

Synlogic

TC BioPharm (Holdings) plc - American Depositary Shares

TC BioPharm (Holdings)

Tenax Therapeutics

Leerink Partners

Stifel

SVB Leerink

Morgan Stanley

Bolt Technology

Comments

Bolt Biotherapeutics

Bolt Biotherapeutics (BOLT) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga